151 related articles for article (PubMed ID: 11872627)
1. Variable promoter region CpG island methylation of the putative tumor suppressor gene Connexin 26 in breast cancer.
Tan LW; Bianco T; Dobrovic A
Carcinogenesis; 2002 Feb; 23(2):231-6. PubMed ID: 11872627
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of connexin 26 in human lung cancer is related to promoter methylation.
Chen Y; Hühn D; Knösel T; Pacyna-Gengelbach M; Deutschmann N; Petersen I
Int J Cancer; 2005 Jan; 113(1):14-21. PubMed ID: 15386363
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the connexin26 tumor suppressor gene expression through methylation in human mammary epithelial cell lines.
Singal R; Tu ZJ; Vanwert JM; Ginder GD; Kiang DT
Anticancer Res; 2000; 20(1A):59-64. PubMed ID: 10769635
[TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
5. The expression of the tumor suppressor gene connexin 26 is not mediated by methylation in human esophageal cancer cells.
Loncarek J; Yamasaki H; Levillain P; Milinkevitch S; Mesnil M
Mol Carcinog; 2003 Feb; 36(2):74-81. PubMed ID: 12557263
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers.
Bae SI; Lee HS; Kim SH; Kim WH
Br J Cancer; 2002 Jun; 86(12):1888-92. PubMed ID: 12085181
[TBL] [Abstract][Full Text] [Related]
7. Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells.
Worm J; Kirkin AF; Dzhandzhugazyan KN; Guldberg P
J Biol Chem; 2001 Oct; 276(43):39990-40000. PubMed ID: 11509559
[TBL] [Abstract][Full Text] [Related]
8. Methylation of specific CpG sites in the promoter region could significantly down-regulate p16(INK4a) expression in gastric adenocarcinoma.
Song SH; Jong HS; Choi HH; Kang SH; Ryu MH; Kim NK; Kim WH; Bang YJ
Int J Cancer; 2000 Jul; 87(2):236-40. PubMed ID: 10861481
[TBL] [Abstract][Full Text] [Related]
9. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma.
Rubinstein JC; Tran N; Ma S; Halaban R; Krauthammer M
BMC Med Genomics; 2010 Feb; 3():4. PubMed ID: 20144234
[TBL] [Abstract][Full Text] [Related]
11. PAX6 methylation and ectopic expression in human tumor cells.
Salem CE; Markl ID; Bender CM; Gonzales FA; Jones PA; Liang G
Int J Cancer; 2000 Jul; 87(2):179-85. PubMed ID: 10861471
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of mouse delta-opioid receptor gene by CpG methylation: involvement of Sp3 and a methyl-CpG-binding protein, MBD2, in transcriptional repression of mouse delta-opioid receptor gene in Neuro2A cells.
Wang G; Wei LN; Loh HH
J Biol Chem; 2003 Oct; 278(42):40550-6. PubMed ID: 12890683
[TBL] [Abstract][Full Text] [Related]
13. Hyper-methylation of the upstream CpG island shore is a likely mechanism of GPER1 silencing in breast cancer cells.
Manjegowda MC; Gupta PS; Limaye AM
Gene; 2017 May; 614():65-73. PubMed ID: 28286086
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer.
Kulak MV; Cyr AR; Woodfield GW; Bogachek M; Spanheimer PM; Li T; Price DH; Domann FE; Weigel RJ
Oncogene; 2013 Aug; 32(34):4043-51. PubMed ID: 22964634
[TBL] [Abstract][Full Text] [Related]
15. Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture.
Stimson KM; Vertino PM
J Biol Chem; 2002 Feb; 277(7):4951-8. PubMed ID: 11733524
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation down-regulates CDX1 gene expression in colorectal cancer cell lines.
Suh ER; Ha CS; Rankin EB; Toyota M; Traber PG
J Biol Chem; 2002 Sep; 277(39):35795-800. PubMed ID: 12124393
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation-dependent silencing of CST6 in human breast cancer cell lines.
Rivenbark AG; Jones WD; Coleman WB
Lab Invest; 2006 Dec; 86(12):1233-42. PubMed ID: 17043665
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic down-regulation of death-associated protein kinase in lung cancers.
Toyooka S; Toyooka KO; Miyajima K; Reddy JL; Toyota M; Sathyanarayana UG; Padar A; Tockman MS; Lam S; Shivapurkar N; Gazdar AF
Clin Cancer Res; 2003 Aug; 9(8):3034-41. PubMed ID: 12912953
[TBL] [Abstract][Full Text] [Related]
19. Silencing of the thrombomodulin gene in human malignant melanoma.
Furuta J; Kaneda A; Umebayashi Y; Otsuka F; Sugimura T; Ushijima T
Melanoma Res; 2005 Feb; 15(1):15-20. PubMed ID: 15714116
[TBL] [Abstract][Full Text] [Related]
20. CpG methylation of promoter region inactivates E-cadherin gene in renal cell carcinoma.
Nojima D; Nakajima K; Li LC; Franks J; Ribeiro-Filho L; Ishii N; Dahiya R
Mol Carcinog; 2001 Sep; 32(1):19-27. PubMed ID: 11568972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
